Cementless Total Knee System (TKS) Market Share

Statistics for the 2023 & 2024 Cementless Total Knee System (TKS) market share, created by Mordor Intelligence™ Industry Reports. Cementless Total Knee System (TKS) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Cementless Total Knee System (TKS) Industry

The cementless total knee system (TKS) market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold large market shares and are well known. include Stryker, Smith & Nephew, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), B. Braun SE, Olympus Corporation (GROUP FH ORTHO), DJO, LLC (Enovis), X.NOV (C2F IMPLANTS), and Beijing Chunlizhengda Medical Instruments Co., Ltd., among others.

Cementless Total Knee System (TKS) Market Leaders

  1. Stryker

  2. Smith & Nephew

  3. Zimmer Biomet

  4. Johnson & Johnson (DePuy Synthes)

  5. B. Braun SE

  6. Olympus Corporation (GROUP FH ORTHO)

*Disclaimer: Major Players sorted in no particular order

Cementless Total Knee System (TKS) Market Concentration

Cementless Total Knee System (TKS) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)